Patents by Inventor SHEN-YUNG KAO

SHEN-YUNG KAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal delivery system containing methylphenidate or its salts and methods thereof
    Patent number: 10537532
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: January 21, 2020
    Assignee: TAHO PHARMACEUTICALS LTD.
    Inventors: Shen-Yung Kao, Taijung Wu, Catherine Lee
  • Transdermal delivery system containing methylphenidate or its salts and methods thereof
    Patent number: 10420733
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: September 24, 2019
    Assignee: TAHO PHARMACEUTICALS LTD.
    Inventors: Shen-Yung Kao, Taijung Wu, Catherine Lee
  • TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF
    Publication number: 20180263922
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Application
    Filed: April 24, 2018
    Publication date: September 20, 2018
    Inventors: Shen-Yung KAO, Taijung WU, Catherine LEE
  • TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF
    Publication number: 20180263923
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Application
    Filed: April 24, 2018
    Publication date: September 20, 2018
    Inventors: Shen-Yung KAO, Taijung WU, Catherine LEE
  • Transdermal delivery system containing methylphenidate or its salts and methods thereof
    Patent number: 9980921
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: May 29, 2018
    Assignee: TAHO PHARMACEUTICALS LTD.
    Inventors: Shen-Yung Kao, Taijung Wu, Catherine Lee
  • TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF
    Publication number: 20180000746
    Abstract: Disclosed herein is a transdermal delivery system comprising methylphenidate or its salt as an active ingredient. Also provided are methods of delivering a therapeutically effective amount of methylphenidate to a subject for the treatment of a disease condition. The disease condition includes a neurological condition such as Attention Deficit Disorder (ADD) and/or Attention Deficit/Hyperactivity Disorder (ADHD). Kits including the transdermal delivery system and methods of making and using the transdermal delivery system are also provided.
    Type: Application
    Filed: June 27, 2017
    Publication date: January 4, 2018
    Inventors: SHEN-YUNG KAO, TAIJUNG WU, CATHERINE LEE